Sectoral Asset Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Sectoral Asset Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-74,150	Closed	-$8.06M	–	68
2016 Q4	$8.06M	Buy	74,150 +3,499	+5%	+$417K	0.89%	31
2016 Q3	$11.6M	Buy	70,651 +16,000	+29%	+$2.52M	1.14%	32
2016 Q2	$7.8M	Sell	54,651 -190,796	-78%	-$27.8M	0.81%	32
2016 Q1	$31.5M	Buy	245,447 +25,400	+12%	+$3M	1.52%	21
2015 Q4	$32.9M	Buy	220,047 +400	+0.2%	+$67.7K	1.4%	21
2015 Q3	$36.4M	Buy	219,647 +42,000	+24%	+$9.24M	1.67%	17
2015 Q2	$42.9M	Buy	177,647 +12,700	+8%	+$3.38M	1.79%	17
2015 Q1	$46.5M	Sell	164,947 -16,900	-9%	-$3.66M	1.77%	19
2014 Q4	$28.4M	Buy	181,847 +103,954	+133%	+$19.2M	1.27%	30
2014 Q3	$18.4M	Buy	77,893 +3,900	+5%	+$994K	0.78%	39
2014 Q2	$17.5M	Sell	73,993 -500	-0.7%	-$132K	0.74%	38
2014 Q1	$24.6M	Buy	+74,493	New	+$25.1M	1.01%	34

Other funds holding ICPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Sectoral Asset Management's ICPT Position: Q1 2017 in Review

Sectoral Asset Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q1 2017, closing a stake of 74,150 shares — an estimated $8.06M sold.

Sectoral Asset Management first reported a position in ICPT in Q1 2014 and held it in 12 quarters. The position peaked at $46.5M in Q1 2015. 150 funds tracked by Wall St. Rank hold ICPT as of Q1 2017.

Sectoral Asset Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Sectoral Asset Management sold 74,150 Intercept Pharmaceuticals, Inc. shares in Q1 2017, an estimated $8.06M.
Sectoral Asset Management first reported a position in Intercept Pharmaceuticals, Inc. in Q1 2014 and held it in 12 quarters.
Sectoral Asset Management's Intercept Pharmaceuticals, Inc. position peaked at $46.5M in Q1 2015.
150 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q1 2017.

Based on Sectoral Asset Management's 13F filing for Q1 2017, filed 15 May 2017.